US Stock MarketDetailed Quotes

ZJYL Jin Medical International

Watchlist

3.400
+0.030+0.89%

Close May 15 16:00 ET

532.26MMarket Cap188.89P/E (TTM)

Jin Medical International Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Sep 30, 2023

(FY)Sep 30, 2022

(FY)Sep 30, 2021

(FY)Sep 30, 2020

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

96.53%3.11M

-72.95%1.58M

133.43%5.84M

2.5M

Net income from continuing operations

6.34%2.88M

2.84%2.71M

19.30%2.63M

--2.21M

Operating gains losses

---6.86K

----

3,741.09%13.37K

--348

Depreciation and amortization

-37.70%225.9K

4.61%362.6K

5.06%346.61K

--329.91K

Deferred tax

204.16%89.6K

-5,072.76%-86.02K

97.87%-1.66K

---77.92K

Change In working capital

85.97%-200.81K

-148.33%-1.43M

8,597.76%2.96M

---34.86K

-Change in receivables

-212.71%-376.08K

-89.16%333.66K

173.60%3.08M

--1.12M

-Change in inventory

408.38%1.56M

-209.98%-504.39K

133.45%458.61K

---1.37M

-Change in prepaid assets

-266.31%-716.36K

154.36%430.74K

-4,642.58%-792.44K

---16.71K

-Change in payables and accrued expense

26.92%-684.07K

-117.80%-936.03K

-233.18%-429.77K

--322.7K

-Change in other working capital

102.68%20.26K

-216.60%-755.37K

785.46%647.86K

---94.51K

Cash from discontinued investing activities

Operating cash flow

96.53%3.11M

-72.95%1.58M

133.43%5.84M

--2.5M

Investing cash flow

Cash flow from continuing investing activities

-6,293.71%-7.73M

88.68%-120.9K

45.49%-1.07M

-1.96M

Net PPE purchase and sale

-158.43%-103.8K

6.33%-40.17K

69.83%-42.88K

---142.11K

Net investment purchase and sale

-1,613.17%-7.63M

45.02%-445.17K

-383.72%-809.73K

--285.4K

Net other investing changes

----

269.48%364.43K

89.77%-215.03K

---2.1M

Cash from discontinued investing activities

Investing cash flow

-6,293.71%-7.73M

88.68%-120.9K

45.49%-1.07M

---1.96M

Financing cash flow

Cash flow from continuing financing activities

5,571.18%6.91M

104.25%121.86K

-734.59%-2.87M

-343.91K

Net issuance payments of debt

--4.25M

--0

-678.54%-2.77M

---355.32K

Net common stock issuance

--8M

--0

----

Proceeds from stock option exercised by employees

--336.64K

--0

----

Net other financing activities

-4,761.29%-5.68M

217.30%121.86K

-1,009.98%-103.88K

--11.42K

Cash from discontinued financing activities

Financing cash flow

5,571.18%6.91M

104.25%121.86K

-734.59%-2.87M

---343.91K

Net cash flow

Beginning cash position

30.51%4.79M

120.75%3.67M

-14.34%1.66M

--1.94M

Current changes in cash

44.59%2.29M

-16.99%1.58M

849.08%1.91M

--200.77K

Effect of exchange rate changes

67.50%-149.9K

-546.49%-461.24K

121.56%103.3K

---479.21K

End cash Position

44.59%6.93M

30.51%4.79M

120.75%3.67M

--1.66M

Free cash flow

94.25%2.99M

-73.44%1.54M

145.69%5.8M

--2.36M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(FY)Sep 30, 2023	(FY)Sep 30, 2022	(FY)Sep 30, 2021	(FY)Sep 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	96.53%3.11M	-72.95%1.58M	133.43%5.84M	2.5M
Net income from continuing operations	6.34%2.88M	2.84%2.71M	19.30%2.63M	--2.21M
Operating gains losses	---6.86K	----	3,741.09%13.37K	--348
Depreciation and amortization	-37.70%225.9K	4.61%362.6K	5.06%346.61K	--329.91K
Deferred tax	204.16%89.6K	-5,072.76%-86.02K	97.87%-1.66K	---77.92K
Change In working capital	85.97%-200.81K	-148.33%-1.43M	8,597.76%2.96M	---34.86K
-Change in receivables	-212.71%-376.08K	-89.16%333.66K	173.60%3.08M	--1.12M
-Change in inventory	408.38%1.56M	-209.98%-504.39K	133.45%458.61K	---1.37M
-Change in prepaid assets	-266.31%-716.36K	154.36%430.74K	-4,642.58%-792.44K	---16.71K
-Change in payables and accrued expense	26.92%-684.07K	-117.80%-936.03K	-233.18%-429.77K	--322.7K
-Change in other working capital	102.68%20.26K	-216.60%-755.37K	785.46%647.86K	---94.51K
Cash from discontinued investing activities
Operating cash flow	96.53%3.11M	-72.95%1.58M	133.43%5.84M	--2.5M
Investing cash flow
Cash flow from continuing investing activities	-6,293.71%-7.73M	88.68%-120.9K	45.49%-1.07M	-1.96M
Net PPE purchase and sale	-158.43%-103.8K	6.33%-40.17K	69.83%-42.88K	---142.11K
Net investment purchase and sale	-1,613.17%-7.63M	45.02%-445.17K	-383.72%-809.73K	--285.4K
Net other investing changes	----	269.48%364.43K	89.77%-215.03K	---2.1M
Cash from discontinued investing activities
Investing cash flow	-6,293.71%-7.73M	88.68%-120.9K	45.49%-1.07M	---1.96M
Financing cash flow
Cash flow from continuing financing activities	5,571.18%6.91M	104.25%121.86K	-734.59%-2.87M	-343.91K
Net issuance payments of debt	--4.25M	--0	-678.54%-2.77M	---355.32K
Net common stock issuance	--8M	--0	--0	----
Proceeds from stock option exercised by employees	--336.64K	--0	--0	----
Net other financing activities	-4,761.29%-5.68M	217.30%121.86K	-1,009.98%-103.88K	--11.42K
Cash from discontinued financing activities
Financing cash flow	5,571.18%6.91M	104.25%121.86K	-734.59%-2.87M	---343.91K
Net cash flow
Beginning cash position	30.51%4.79M	120.75%3.67M	-14.34%1.66M	--1.94M
Current changes in cash	44.59%2.29M	-16.99%1.58M	849.08%1.91M	--200.77K
Effect of exchange rate changes	67.50%-149.9K	-546.49%-461.24K	121.56%103.3K	---479.21K
End cash Position	44.59%6.93M	30.51%4.79M	120.75%3.67M	--1.66M
Free cash flow	94.25%2.99M	-73.44%1.54M	145.69%5.8M	--2.36M
Currency Unit	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall